TACC3 and carcinoma: There are three likely reasons for this phenomenon: (1) stage IV patients accounted for only a small proportion of the total patient population (17/237), which might skew the results; (2) stage IV tumors usually occur with hepatic dysfunction, which may affect the prognosis; and (3) TACC3 levels were absolutely correlated to the stage of carcinoma.